CAS 1962925-29-6 appears in our catalog under these names: Nirogacestat dihydrobromide, PF 3084014 hydrobromide, Pf 3084014 hydrobromide, Nirogacestat (dihydrobromide), 99.9%, (S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide dihydrobromide, 98%. Offered by: TargetMol, GLPBio, Biosynth, MedChemExpress, Chemat. Available pack sizes: 10mg, 50mg, 100mg, 5 mg, 100 mg, 10mM/1mL, 50 mg, 10 mg.
Nirogacestat dihydrobromide is a hydrobromide salt obtained by reaction of nirogacestat with two equivalents of hydrobromic acid. It has a role as an antineoplastic agent and a gamma-secretase modulator. It contains a nirogacestat(2+).
Source: ChEBI
| Molecular formula | C27H43Br2F2N5O |
|---|---|
| Molecular weight | 651.5 g/mol |
| IUPAC name | (2S)-2-[[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide;dihydrobromide |
| InChIKey | LXEYYZYDWLAIPW-KBVFCZPLSA-N |
| SMILES | CCC[C@@H](C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)N[C@H]2CCC3=C(C2)C(=CC(=C3)F)F.Br.Br |
Computed by PubChem (NCBI)